Indrani Lall Franchini, EVP, Chief Compliance Officer at ALEXION PHARMACEUTICALS, INC. (ALXN), sold 5,210 shares at $118.13 ($615K) on 2018-11-28, disclosed to the SEC on 2018-11-30.
Open-market sale of $615k ALXN by EVP, Chief Compliance Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $118.13 | 2,605 | $308K | 50.0% |
| 2 | $118.13 | 2,605 | $308K | 50.0% |
| Total | $118.13 avg | 5,210 | $615K | 100% |
| Filing → |
| ALNY | SELL | 2023-04-10 | $735K | — | Filing → |
| ALNY | SELL | 2023-02-03 | $739K | — | Filing → |
| ALXN | SELL | 2020-06-09 | $1.4M | — | Filing → |